Stacey Shoop
Medical · Santa Ana, CANPI 1104222124
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (41.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Angiodynamics, Inc. at 41.1% of the total. Reporting peaked in 2023 at $22,331 and has fallen 74.7% since, to $5,658 in 2025. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 775 payments — averaging $84.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$27K
- Amgen$9K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$9K
- Edwards Lifesciences$5K
- Medtronic$3K
- Novo Nordisk$3K
- plus $9K from 34 others
What the payments were for
- Consulting fees$5,7259%
- Speaking & faculty fees$15,40023%
- Travel & lodging$2190%
- Food & beverage$17,11926%
- Education$2970%
- Other$27,05641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$27,056
- Repatha$8,734
- LifeVest$8,099
- Micra$859
- Azure$525
- Ozempic$478
- XARELTO$387
- Confirm Rx$325
- LINQ II$165
- MERLIN@HOME$150
- AVEIR$150
- Kerendia$150
- MOUNJARO$120
- LUX-DX$120
- JARDIANCE$120
- Inpefa$116
- Wegovy$115
- AZURE XT DR MRI SURESCAN$112
- Reveal LINQ$106
- ASSURITY$102
How this compares
$65,815 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 248 | $275,927 |
| OzempicSemaglutide | 145 | $144,114 |
| XareltoRivaroxaban | 128 | $122,138 |
| EntrestoSacubitril/Valsartan | 80 | $90,548 |
| FarxigaDapagliflozin Propanediol | 99 | $82,541 |
| RybelsusSemaglutide | 21 | $51,368 |
| KerendiaFinerenone | 29 | $34,948 |
| EliquisApixaban | 38 | $33,772 |
| MounjaroTirzepatide | 23 | $30,368 |
| VascepaIcosapent Ethyl | 70 | $29,403 |
| TrulicityDulaglutide | 27 | $25,714 |
| Repatha SureclickEvolocumab | 43 | $24,793 |
| Icosapent Ethyl | 89 | $19,789 |
| VerquvoVericiguat | 11 | $19,084 |
| Repatha SyringeEvolocumab | 13 | $7,765 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $931 | $275,927248 claims |
| Novo NordiskOzempic, Rybelsus | $2,964 | $195,482166 claims |
| Johnson & JohnsonXarelto | $1,088 | $122,138128 claims |
| NovartisEntresto | $730 | $90,54880 claims |
| AstraZenecaFarxiga | $654 | $82,54199 claims |
| Lilly USA, LLCMounjaro, Trulicity | $668 | $56,08250 claims |
| BayerKerendia | $366 | $34,94829 claims |
| PfizerEliquis | $171 | $33,77238 claims |
| MerckVerquvo | $482 | $19,08411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in Santa Ana
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.